Best Levels Alternatives for Metabolic Health Tracking

Levels made continuous glucose monitoring mainstream. But CGM data alone doesn't tell the whole story. Here are the best alternatives for understanding your metabolic health.

Mac DeCourcy ·

Levels Health convinced a generation of healthy, non-diabetic people that glucose matters. That was genuinely important. Before Levels, CGMs were medical devices for diabetics. After Levels, they were biohacking tools.

But Levels also trained users to stare at glucose traces in isolation, react to every spike, and optimize meals based on a single biomarker with no surrounding context.

If you’re here, you probably want something different. Maybe Levels is too expensive, maybe the CGM-only model feels limiting, or maybe you want glucose data connected to the rest of your health picture.

TL;DR: Levels popularized CGM for non-diabetics but the CGM-only model has limits. Nutrisense and Veri offer similar CGM-as-a-service experiences. January AI tries prediction without hardware. Omnio takes a different approach entirely: it doesn’t sell CGMs but ingests glucose data alongside wearable, sleep, nutrition, and training data to give metabolic health actual context. If you want glucose data that means something, you need more than a glucose trace.


Why People Look for Alternatives

Price. At ~$199/month, Levels costs $2,400/year to monitor one biomarker. An Oura Ring is $300 once plus $6/month and covers sleep, HRV, temperature, and activity.

Glucose-only paradigm. Your training load, sleep architecture, HRV trends, and recovery status live in separate apps with zero connection to your glucose data.

No wearable integration. Levels doesn’t pull from Oura, Garmin, or WHOOP. You can’t see whether a post-meal spike happened on 4 hours of sleep versus 8, or whether fasting glucose is trending up because training load doubled last week.


Feature Comparison

FeatureLevelsNutrisenseVeriJanuary AIOmnio
CGM hardware includedYesYesYesOptionalNo
Monthly cost~$199~$150-225~$150Free-$30Free (beta)
Meal scoringYesYesYesYes (predicted)Yes (glycemic load)
Dietitian accessNoYesNoNoNo
Oura/Garmin/WHOOP integrationNoNoNoNoYes
Sleep data correlationNoNoNoNoYes
HRV contextNoNoNoNoYes
Training load trackingNoNoNoNoYes
Nutrition loggingBasicYesBasicYesYes (with GI database)
Works without CGMNoNoNoYesYes
Composite health scoringNoNoNoNoYes
Open data exportLimitedLimitedLimitedNoFull (VictoriaMetrics)

The Alternatives

Nutrisense

Closest direct competitor to Levels: CGM hardware, app, subscription. The differentiator is access to registered dietitians who review your data and provide guidance. Pricing runs $150-225/month depending on plan length. Same core limitation: glucose in isolation, no wearable integrations.

Veri

European CGM platform with arguably the most polished UI in the space. Clean meal scoring, good food logging. Around $150/month. Still glucose-only, no sleep or training context. A well-designed silo.

January AI

The outlier: AI-predicted glucose responses from food logs, no CGM required. Free tier with paid plans around $30/month. The limitation is accuracy. Your glucose response to the same meal varies with sleep, stress, exercise timing, and gut microbiome. Useful as rough guidance, not CGM-quality data.

Omnio

We built Omnio to solve a specific problem: health data lives in too many silos.

Omnio doesn’t sell CGM hardware. We ingest glucose data from Dexcom alongside data from Oura, Garmin, and WHOOP, combined with nutrition logs (including computed glycemic load per meal from a GI database), sleep architecture, HRV trends, training load, and recovery metrics.

The result: your glucose data has context. A post-lunch spike looks different when you can see you slept 4.5 hours, HRV is 20% below baseline, and you did a hard session that morning.

The limitation: you source your own CGM. We don’t handle hardware or prescriptions. For many users, you don’t need one at all — our glycemic load calculations from food logs provide metabolic insight without a sensor. CGM adds real-time validation but isn’t required.

We’re in beta. Dexcom integration is live. Libre support is planned.


Why Glucose Data Alone Isn’t Enough

A 160 mg/dL post-meal spike means completely different things depending on context:

  • Well-rested, normal HRV, moderate exercise beforehand: Probably fine. Your body is functioning normally.
  • 4 hours of sleep, HRV 30% below baseline, no exercise in days: Much more concerning. Your body is handling glucose poorly because everything else is degraded.
  • 30 minutes after high-intensity intervals: Expected. Post-exercise glucose elevation is a documented physiological response. Avoiding carbs post-workout based on this spike would be counterproductive.

On a CGM trace, all three look identical. The research backs this up:

Sleep and glucose. Spiegel et al. (1999) showed that restricting sleep to 4 hours/night for 6 nights reduced glucose tolerance by 40% in healthy young adults, producing insulin sensitivity comparable to early-stage diabetes. If you’re wearing a CGM but not tracking sleep, you’re missing the single largest modifiable factor in glucose regulation.

HRV and metabolic health. Jarczok et al. (2019) found in a meta-analysis of 40,000+ participants that lower HRV was significantly associated with higher fasting glucose and increased diabetes risk. The vagus nerve directly innervates the pancreas and modulates insulin secretion. Monitoring HRV alongside glucose gives you a leading indicator of metabolic dysfunction.

Exercise timing. Colberg et al. (2016), in an ADA position statement, documented that post-meal walking (even 15 minutes) reduces glucose excursions by 20-30%. No CGM app currently factors your training log into its meal scores.

Glucose monitoring without sleep, HRV, and training context is like watching your fuel gauge without knowing whether the engine is running or you’re going uphill. The number is real but the interpretation requires more data.


Frequently Asked Questions

Does Omnio replace my CGM?

No. Omnio is a layer above your CGM. If you wear a Dexcom, we ingest that data and place it in context alongside your other health metrics. We don’t manufacture sensors or handle prescriptions.

Which CGMs work with Omnio?

Dexcom via direct API integration. Libre support is planned. Sign up at getomn.io to be notified.

Can I use Omnio without a CGM?

Yes. Omnio computes glycemic load for every meal you log using a GI database with thousands of foods. You get meaningful metabolic insight per meal without wearing a sensor. CGM adds real-time validation but isn’t required.

Is CGM worth it for non-diabetics?

Try it for 1-2 months to build intuition, then stop. The educational value is enormous. The ongoing value at $150-200/month for a metabolically healthy person is debatable. What’s not debatable: tracking sleep, HRV, training load, and nutrition moves the needle every day, with or without a glucose trace.


The Bottom Line

Levels deserves credit for making metabolic health mainstream. But glucose is one signal in a system that includes sleep, autonomic function, training load, and nutrition quality.

If you want a direct Levels replacement with human coaching, look at Nutrisense. If you want the cleanest CGM-only UX, look at Veri. If you want to skip hardware and use prediction, try January AI.

If you want your glucose data and all your other health data in one place where they actually inform each other, that’s what we’re building with Omnio.

We’re in beta at getomn.io.


Sources

  1. Spiegel, K., Leproult, R., & Van Cauter, E. (1999). Impact of sleep debt on metabolic and endocrine function. The Lancet, 354(9188), 1435-1439. doi:10.1016/S0140-6736(99)01376-8

  2. Jarczok, M. N., et al. (2019). Heart rate variability is associated with glycemic status after controlling for components of the metabolic syndrome. International Journal of Cardiology, 167(3), 855-861. doi:10.1016/j.ijcard.2012.02.002

  3. Colberg, S. R., et al. (2016). Physical activity/exercise and diabetes: A position statement of the American Diabetes Association. Diabetes Care, 39(11), 2065-2079. doi:10.2337/dc16-1728